User login

Enter your username and password here in order to log in on the website:

Forgot your password?

05.01.2021

SYNLAB substantially completes divestment of Analytics & Services business to SGS

  • SYNLAB is now focussing on its core medical activities and drives further growth
  • SYNLAB CEO: “This transaction adds great value to both SYNLAB and A&S. SYNLAB is now able to fully focus on its core medical activities, while A&S is benefiting from its new owner who is a leading expert in its specific market segment. Together we have created growth prospects for all involved.”

 

SYNLAB, the leading medical diagnostic services provider in Europe, announces the substantial completion of the divestment of its Analytics & Services (A&S) unit to SGS on 31 December 2020. SGS is the world’s leading inspection, verification, testing and certification company.

A&S is a leading European provider for environment, food, hygiene, pharma and products analysis and testing. In 2019, A&S generated sales revenues of more than EUR 200m and had approximately 2,000 employees.

As part of SGS, A&S is now able to benefit from scale in its market segment and leverage new opportunities for future growth. At the same time, the transaction enables SYNLAB to fully concentrate on expanding its core medical activities.

Mathieu Floreani, CEO of SYNLAB Group: “This transaction adds great value to both SYNLAB and A&S. SYNLAB is now able to fully focus on its core medical activities, while A&S is benefiting from its new owner who is a leading expert in its specific market segment. Together we have created growth prospects for all involved.”

 

Download: PDF | Press release: SYNLAB completes sale of Analytics & Services business to SGS.pdf